Goldenwell Biotech GWLL Cash Flow Statement (2019-2026)

OTC GWLL
$0.69 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Goldenwell Biotech Quarterly Cash Flow Statement

Periods 27 quarters
Latest Jun 2026

Goldenwell Biotech reported cash from operations of -$47271.00 and free cash flow of -$47271.00 for the quarter ended Jun 2026, down 179.6% year over year. This cash flow statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18014.00-29554.00-33380.00-26800.00-4584.00-920332.00-33606.00-27084.00-35406.00-20799.00-31056.00-49920.00-23065.00-27452.00-38536.00-30300.00-27895.00-24995.00-17606.00-34776.00
Asset Writedowns and ImpairmentWritedown
5,573.00188.00711.00174,745.00
Cash from OperationsCash from Ops.
-12506.00-19373.00-145655.00-25037.0015,222.00-917090.00-31921.00-26946.00-35210.00-19076.00-29010.00-47751.00-20965.00-25351.00-32276.0059,380.00-30885.00-18848.00-13361.00-47271.00
Change in Working Capital
Change in ReceivablesChange Receivables
857.00
Change in InventoryChange Inventory
-5250.00-1804.00-1763.00-20663.0045,227.00711.00-138.00-196.00-2240.00-69.0073.00-43.00-174745.00
Change in Account PayablesChange Payables
8,363.00-111488.00
Change in Accured ExpensesChange Accured Exp.
-111488.00
Other Working Capital ChangesOther WC Changes
-5572.00-3690.00-7427.00-7486.00-3740.00-3754.00-25372.00-54.00-54.00-1860.00
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
30,000.0030,000.0060,388.0049,250.0070,000.0045,000.00
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Change in Cash
-12506.00-19373.00-145655.00-25037.0015,222.00-12090.00-1921.00-26946.00-5210.0041,312.00-29010.001,499.00-20965.0044,649.00-32276.0059,380.00-30885.00-18848.00-13361.00-2271.00
Free Cash FlowFCF
-12506.00-19373.00-145655.00-25037.0015,222.00-917090.00-31921.00-26946.00-35210.00-19076.00-29010.00-47751.00-20965.00-25351.00-32276.0059,380.00-30885.00-18848.00-13361.00-47271.00
Net Cash FlowNCF
-12506.00-19373.00-145655.00-25037.0015,222.00-917090.00-1921.00-26946.00-5210.0041,312.00-29010.001,499.00-20965.0044,649.00-32276.0059,380.00-30885.00-18848.00-13361.00-2271.00

Goldenwell Biotech Cash Flow Statement API

Pull Goldenwell Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GWLL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY